| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,602 |
3,964 |
$130K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,481 |
1,641 |
$80K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,396 |
944 |
$54K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,449 |
1,491 |
$34K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,417 |
1,053 |
$25K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
655 |
366 |
$21K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
611 |
511 |
$19K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
226 |
147 |
$10K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
454 |
239 |
$10K |
| 87634 |
|
94 |
79 |
$3K |
| 87631 |
|
47 |
25 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
504 |
355 |
$3K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
305 |
64 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
107 |
63 |
$1K |
| 96127 |
|
183 |
164 |
$1K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
94 |
71 |
$1K |
| 96160 |
|
135 |
126 |
$569.90 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
71 |
39 |
$564.41 |
| 87807 |
|
142 |
101 |
$497.80 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
88 |
42 |
$365.91 |
| 81002 |
|
189 |
110 |
$216.91 |
| 36415 |
Collection of venous blood by venipuncture |
47 |
45 |
$124.20 |
| 99422 |
|
24 |
18 |
$58.72 |
| 0011A |
|
13 |
13 |
$28.80 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
90 |
42 |
$6.11 |
| H0033 |
Oral medication administration, direct observation |
25 |
14 |
$0.00 |